Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population

Teratology

Volumn 59, Issue 5, 1999, Pages 331-341

  Trembath, Dimitri ^a   Sherbondy, Andrea L ^a   Vandyke, Don C ^a   Shaw, Gary M ^b   Todoroff, Karen ^b   Lammer, Edward J ^c   Finnell, Richard H ^d   Marker, Stephen ^e   Lerner, Gary ^f   Murray, Jeffrey C ^a,g  

^a UNIVERSITY OF IOWA   (United States)

^b March of Dimes Birth Defects Foundation   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e PARK NICOLLET INSTITUTE   (United States)

^f Childrens Hospital   (United States)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; METHIONINE SYNTHASE; RECEPTOR PROTEIN; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; EXON; FEMALE; FOLATE METABOLISM; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HOMEOBOX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SPINA BIFIDA; STOP CODON; UNITED STATES;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); 5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ALLELES; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; DNA-BINDING PROTEINS; EXONS; FETAL PROTEINS; FOLIC ACID; GENE FREQUENCY; HOMEODOMAIN PROTEINS; HUMANS; LINKAGE DISEQUILIBRIUM; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MIDWESTERN UNITED STATES; MOLECULAR SEQUENCE DATA; MUTATION; NEURAL TUBE DEFECTS; OXIDOREDUCTASES; PAIRED BOX TRANSCRIPTION FACTORS; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS;

MURINAE;

EID: 0032893230     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199905)59:5<331::AID-TERA4>3.0.CO;2-L     Document Type: Article

References (38)

1. Brown CM, Dalphin ME, Stockwell PA, Tate WP. 1993. The translational termination signal database. Nucleic Acids Res 21:3119-3123.
2. Chatkupt S, Hol FA, Shugart YY, Geurds MPA, Stenroos ES, Koenigsberger MR, Hamel BCJ, Johnson WG, Mariman ECM. 1995. Absence of linkage between familial neural tube defects and PAX3 gene. J Med Genet 32:200-204.
3. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. 1997. Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem 272:3628-3634.
4. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
5. de Franchis R, Sebastio g, Mandato C, Andria G, Mastroiacovo P. 1995. Spina bifida, 677T→C mutation, and role of folate [letter]. Lancet 346:1703.
6. Edmonds LD, James LM. 1990. Temporal trends in the prevalence of congenital malformations at birth based on the Birth Defects Monitoring Program, United States, 1979-1987. MMWR 39:19-23.
7. Edwards YH, Putt W, Lekoape KM, Stott D, Fox M, Hopkinson DA, Sowden J. 1996. The human homolog T of the mouse T (Brachyury) gene: Gene structure, cDNA sequence, and assignment of chromosome 6q27. Genome Res 6:226-233.
8. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774.
9. Ewens WJ, Spielman RS. 1995. The transmission disequilibrium test: History, subdivision, and admixture. Am J Hum Genet 57:455-464.
10. Hol FA, Hamel BCJ, Geurds MPA, Mullart RA, Barr FG, Macina RA, Mariman ECM. 1995. A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg Syndrome. J Med Genet 32:52-56.
11. Hook EB, Czeizel A. 1997. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet 350:513-515.
12. Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
13. Lary JM, Edmonds LD. 1996. Prevalence of spina bifida at birth -United States, 1983-1990: A comparison of two surveillance systems. MMWR 45:15-26.
14. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA. 1996. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5:1867-1874.
15. Li YN, Gulati S, Baker PJ, Brody LC, Banderjee R, Kruger WD. 1996. Cloning, mapping, and RNA analysis of the human methionine synthase gene. Hum Mol Genet 5:1851-1858.
16. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
17. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
18. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. 1991. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-2852.
19. Mornet E, Muller F, Lenvoise-Furet A, Delezoide A, Col J, Simon-Bouy B, Serre J. 1997. Screening of the c677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
20. Morrison K, Charalambos P, Attwood J, Hol F, Lynch SA, Sampath A, Hamel B, Burn J, Sowden J, Stott D, Mariman E, Edwards YH. 1996. Genetic mapping of the human homologue (T) of the mouse T (Brachyury) and a search for allele association between human T and spina bifida. Hum Mol Genet 5:669-674.
21. Morrison K, Edwards YH, Lynch SA, Burn J, Hol F, Mariman E. 1997. Methionine synthase and neural tube defects. J Med Genet 34:958.
22. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptual use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145.
23. Orr RB, Kamen BA. 1995. Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype. Cancer Res 55:847-855.
24. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakely GP, Adams MJ. 1996. 5, 10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
25. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273:1516-1517.
26. Seller MJ. 1994. Vitamins, folic acid, and the cause and prevention of neural tube defects. Ciba Found Symp 181:161-179.
27. Shaw GM, Rozen R, Finell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148:30-37.
28. Smithells RW, Sheppard S, Wild J, Schorah CJ. 1989. Prevention of neural tube defect recurrences in Yorkshire: Final report. Lancet 2:498-499.
29. Speer MC, Worley G, Wolpert CM, Viles K, Beaty M, Mackey JF, Aylsworth AS, Albright SG, Lucas A, Fuchs HE, George T, Pericak-Vance MA. 1996. Investigations of candidate genes in lumbosacral myelomeningocele. Am J Hum Genet [Suppl] 59:389.
30. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-616.
31. Tate WP, Brown CM. 1992. Translational termination: "stop" for protein synthesis or "pause" for regulation of gene expression. Biochemistry 31:2443-2450.
32. Terwilliger JD. 1995. A powerful likelihood method for analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56:777-787.
33. Van Allen M. 1996. Multisite neural tube closure in humans. Birth Defects 30:203-225.
34. Van Allen MI, Kalousek DK, Chernoff GF, Juriloff D, Harris M, McGillivray BC, Yong S, Langlois S, MacLeod PM, Chiayat D, Friedman JM, Wilson RD, McFadden D, Pantzar J, Ritchie S, Hall J. 1993. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 47:723-743.
35. van der Put N, Steegers-Theunissen R, Frosst P, Trijbels F, Eskes T, van den Heuvel L, Mariman E, Heyer M, Rozen R, Blom H. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
36. van der Put NMJ, van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JMF, Eskes TKAB, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ. 1997. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med 90 511-517.
37. van der Put NMJ, Gabreels F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
38. Zhao Q, Behringer RR, de Crombrugghe B. 1996. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat Genet 13:275-283.